KR20030088043A - 스테로이드 화합물, 이 화합물의 감수분열 조절 약제 제조용도 및 이 화합물의 제조 방법 - Google Patents

스테로이드 화합물, 이 화합물의 감수분열 조절 약제 제조용도 및 이 화합물의 제조 방법 Download PDF

Info

Publication number
KR20030088043A
KR20030088043A KR10-2003-7012456A KR20037012456A KR20030088043A KR 20030088043 A KR20030088043 A KR 20030088043A KR 20037012456 A KR20037012456 A KR 20037012456A KR 20030088043 A KR20030088043 A KR 20030088043A
Authority
KR
South Korea
Prior art keywords
pregna
methyl
substituted
unsubstituted
diene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR10-2003-7012456A
Other languages
English (en)
Korean (ko)
Inventor
토르스텐 블룸
피터 에스퍼링
크리스타 헤겔-할텅
Original Assignee
쉐링 악티엔게젤샤프트
노보 노르디스크 에이/에스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 쉐링 악티엔게젤샤프트, 노보 노르디스크 에이/에스 filed Critical 쉐링 악티엔게젤샤프트
Publication of KR20030088043A publication Critical patent/KR20030088043A/ko
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR10-2003-7012456A 2001-03-26 2002-03-20 스테로이드 화합물, 이 화합물의 감수분열 조절 약제 제조용도 및 이 화합물의 제조 방법 Ceased KR20030088043A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01250108A EP1245572A1 (en) 2001-03-26 2001-03-26 Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation
EP01250108.6 2001-03-26
PCT/EP2002/003148 WO2002079220A2 (en) 2001-03-26 2002-03-20 Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation

Publications (1)

Publication Number Publication Date
KR20030088043A true KR20030088043A (ko) 2003-11-15

Family

ID=8181575

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2003-7012456A Ceased KR20030088043A (ko) 2001-03-26 2002-03-20 스테로이드 화합물, 이 화합물의 감수분열 조절 약제 제조용도 및 이 화합물의 제조 방법

Country Status (18)

Country Link
US (1) US6916921B2 (https=)
EP (2) EP1245572A1 (https=)
JP (1) JP2004534011A (https=)
KR (1) KR20030088043A (https=)
CN (1) CN1332975C (https=)
AU (1) AU2002315260B2 (https=)
BR (1) BR0208381A (https=)
CA (1) CA2438210A1 (https=)
CZ (1) CZ20032578A3 (https=)
HU (1) HUP0303643A2 (https=)
IL (1) IL157272A0 (https=)
MX (1) MXPA03008199A (https=)
NO (1) NO20034273L (https=)
PL (1) PL369576A1 (https=)
RU (1) RU2289587C2 (https=)
UA (1) UA75130C2 (https=)
WO (1) WO2002079220A2 (https=)
ZA (1) ZA200308271B (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100689260B1 (ko) * 2005-05-24 2007-03-02 삼원산업주식회사 항산화성 스틸벤계 형광증백제 및 이의 합성방법

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1514874A1 (en) * 2003-07-28 2005-03-16 Schering Aktiengesellschaft Thiomorpholino steroid compounds, the use thereof for the preparation of meiosis regulating medicaments and method for the preparation thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1095167A (en) * 1963-12-05 1967-12-13 Shalom Sarel Amino-steroids
US3419661A (en) * 1964-01-13 1968-12-31 Univ Missouri Oral contraceptive for birds
DE1643004A1 (de) * 1967-02-07 1971-04-08 Schering Ag Bisnorcholenderivate und Verfahren zu ihrer Herstellung
DE1930473A1 (de) * 1969-06-14 1970-12-17 Schering Ag 22-N-substituierte (20R)-23,24-dinor-cholanderivate
US5716777A (en) 1994-06-23 1998-02-10 Novo Nordisk A/S Regulation of meiosis using sterols
HUP9800731A3 (en) * 1995-03-06 2000-03-28 Novo Nordisk As Stimulation of meiosis
CA2224866A1 (en) 1995-06-23 1997-01-09 Novo Nordisk A/S Meiosis regulating compounds
JP2001506656A (ja) 1996-12-20 2001-05-22 ノボ ノルディスク アクティーゼルスカブ 減数分裂調節化合物
WO1999058549A1 (en) * 1998-05-13 1999-11-18 Novo Nordisk A/S Meiosis regulating compounds
EP1098652A2 (en) 1998-05-26 2001-05-16 Schering Aktiengesellschaft Treatment of infertility with camp-increasing compounds alone or in combination with at least one meiosis-stimulating compound
CN1353617A (zh) 1999-02-24 2002-06-12 诺沃挪第克公司 不孕症的治疗
AU2794000A (en) 1999-02-24 2000-09-14 Novo Nordisk A/S Treatment of infertility
CZ20012671A3 (cs) 1999-02-26 2002-01-16 Novo Nordisk A/S Způsob in vitro oplodnění s pouľitím kultivačního média obsahujícího sterol aktivující meiosu
CA2382908A1 (en) 1999-09-16 2001-03-22 Novo Nordisk A/S Composition for ivf
WO2001062260A2 (en) 2000-02-25 2001-08-30 Schering Aktiengesellschaft Improvement of implantation rate
ATE386495T1 (de) * 2001-02-06 2008-03-15 Novo Nordisk As Behältnis mit niedrigem sauerstoffgehalt, das ff- mas enthält
US6988613B2 (en) * 2001-02-06 2006-01-24 Novo Nordisk A/S Composition for IVF

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100689260B1 (ko) * 2005-05-24 2007-03-02 삼원산업주식회사 항산화성 스틸벤계 형광증백제 및 이의 합성방법

Also Published As

Publication number Publication date
RU2003130228A (ru) 2005-04-10
ZA200308271B (en) 2005-01-24
PL369576A1 (en) 2005-05-02
IL157272A0 (en) 2004-02-19
JP2004534011A (ja) 2004-11-11
CA2438210A1 (en) 2002-10-10
WO2002079220A2 (en) 2002-10-10
NO20034273L (no) 2003-11-25
NO20034273D0 (no) 2003-09-25
CZ20032578A3 (cs) 2003-12-17
UA75130C2 (en) 2006-03-15
CN1332975C (zh) 2007-08-22
US6916921B2 (en) 2005-07-12
EP1245572A1 (en) 2002-10-02
AU2002315260B2 (en) 2008-04-03
HUP0303643A2 (hu) 2004-03-01
WO2002079220A3 (en) 2003-10-16
CN1543473A (zh) 2004-11-03
MXPA03008199A (es) 2004-01-29
US20020188143A1 (en) 2002-12-12
HK1070900A1 (en) 2005-06-30
RU2289587C2 (ru) 2006-12-20
EP1401856A2 (en) 2004-03-31
BR0208381A (pt) 2004-06-15

Similar Documents

Publication Publication Date Title
EP0857173B1 (en) Meiosis regulating compounds
CZ289407B6 (cs) Sterolové deriváty pro výrobu léčiva k regulování meiózy
CA2275683A1 (en) Meiosis regulating compounds
US6518262B1 (en) 22R-hydroxycholesta-8, 14-diene derivatives for the inhibition of meiosis
KR20030088043A (ko) 스테로이드 화합물, 이 화합물의 감수분열 조절 약제 제조용도 및 이 화합물의 제조 방법
WO2006032885A2 (en) 2-substituted estrogen sulphamates for inhibition of steroid sulphatase
AU2002315260A1 (en) Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation
HK1070900B (en) Steroid compounds, use of these compounds for the preparation of meiosis-regulating medicaments and method for the preparation of these compounds
RU2349597C2 (ru) Тиоморфолиновые производные стероидов, их применение для получения регулирующих мейоз лекарственных средств и способ получения этих соединений
US6528501B1 (en) 22s-hydroxycholesta-8, 14-diene derivatives with meiosis regulating activity
JP2001526293A (ja) １７β−アリール（アリールメチル）オキシ（チオ）アルキル−アンドロスタン誘導体
CA2373442A1 (en) 14.beta.-h-sterols, pharmaceutical compositions comprising them and use of these derivatives for the preparation of meiosis regulating medicaments
MXPA06001145A (en) Thiomorpholino steroid compounds, the use thereof for the preparation of meiosis-regulating medicaments and method for the preparation thereof
WO2001062771A1 (en) Steroid derivatives with an additional ring annulated to ring a and use of these derivatives for the preparation of meiosis regulating medicaments
CZ20004566A3 (cs) Nové sloučeniny, jejich použití, způsob regulace meiózy a nový znak
CZ20004175A3 (cs) Sloučeniny regulující meiosu
CZ291308B6 (cs) Sterolové deriváty regulující meiózu a způsob regulace

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20030925

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20070320

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20080218

Patent event code: PE09021S01D

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20080820

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20081128

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20080820

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

Patent event date: 20080218

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I